Teva CEO shuffles management as firm refines restructuring plan – The Globe and Mail
Teva Pharmaceutical Industries Ltd.’s new chief executive officer ousted the company’s three top division heads on Monday as he works to turn around and streamline the operations of the debt-laden drug maker. CEO Kare Schultz, who joined Teva on Nov. 1, said he will combine the Israeli company’s generic and specialty drugs business, as well…